168 related articles for article (PubMed ID: 12097413)
1. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Mishima K; Arakaki R; Suda T; Saito I; Hayashi Y
J Immunol; 2002 Jul; 169(2):1050-7. PubMed ID: 12097413
[TBL] [Abstract][Full Text] [Related]
2. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
[TBL] [Abstract][Full Text] [Related]
4. Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
J Immunol; 2000 Aug; 165(4):2251-7. PubMed ID: 10925313
[TBL] [Abstract][Full Text] [Related]
5. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Hayashi Y; Yayagi K; Haneji N
Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
[TBL] [Abstract][Full Text] [Related]
6. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
Miyazaki K; Takeda N; Ishimaru N; Omotehara F; Arakaki R; Hayashi Y
Am J Pathol; 2005 Oct; 167(4):1051-9. PubMed ID: 16192640
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen.
Saegusa K; Ishimaru N; Haneji N; Yanagi K; Yoneda T; Saito I; Hayashi Y
Scand J Immunol; 2000 Sep; 52(3):264-70. PubMed ID: 10972902
[TBL] [Abstract][Full Text] [Related]
8. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
9. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
[TBL] [Abstract][Full Text] [Related]
10. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
11. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
[TBL] [Abstract][Full Text] [Related]
12. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.
Ishimaru N; Arakaki R; Watanabe M; Kobayashi M; Miyazaki K; Hayashi Y
Am J Pathol; 2003 Oct; 163(4):1481-90. PubMed ID: 14507655
[TBL] [Abstract][Full Text] [Related]
13. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
Clin Exp Immunol; 2000 Feb; 119(2):354-60. PubMed ID: 10632675
[TBL] [Abstract][Full Text] [Related]
14. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.
Ishimaru N; Yoneda T; Saegusa K; Yanagi K; Haneji N; Moriyama K; Saito I; Hayashi Y
Am J Pathol; 2000 May; 156(5):1557-64. PubMed ID: 10793067
[TBL] [Abstract][Full Text] [Related]
15. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
16. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
17. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
18. Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death.
Nagaraju K; Cox A; Casciola-Rosen L; Rosen A
Arthritis Rheum; 2001 Oct; 44(10):2376-86. PubMed ID: 11665980
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity.
Maruyama T; Saito I; Hayashi Y; Kompfner E; Fox RI; Burton DR; Ditzel HJ
Am J Pathol; 2004 Jul; 165(1):53-61. PubMed ID: 15215161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]